Integer Holdings Corporation (NYSE:ITGR) Stock Has Consensus Target Price of $113.67 According to Brokerages

Shares of Integer Holdings Corporation (NYSE:ITGR) have earned a consensus recommendation of “Hold” from the twelve ratings firms that are covering the stock, Marketbeat Ratings reports. Eleven investment analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $113.67.

Several brokerages have issued reports on ITGR. Weiss Ratings raised shares of Integer from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, October 23rd. HC Wainwright restated a “buy” rating on shares of Integer in a research note on Friday, July 24th. Freedom Capital downgraded shares of Integer from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 4th. Citigroup lifted their target price on shares of Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a research report on Wednesday, July 8th. Finally, Benchmark lowered shares of Integer from a “buy” rating to a “hold” rating in a research report on Thursday, August 13th.

Insider Activity at Integer

In other Integer news, insider Andrew Senn sold 9,408 shares of Integer stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $126.30, for a total value of $1,188,230.40. Following the completion of the transaction, the insider owned 5,405 shares in the company, valued at approximately $682,651.50. The trade was a 63.51% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Kirk Thor sold 19,773 shares of the business’s stock in a transaction on Monday, September 14th. The stock was sold at an average price of $126.25, for a total value of $2,496,341.25. Following the completion of the transaction, the insider directly owned 18,920 shares in the company, valued at approximately $2,388,650. This represents a 51.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 40,948 shares of company stock worth $5,169,920 over the last three months. 1.10% of the stock is owned by company insiders.

Institutional Investors Weigh In On Integer

A number of hedge funds have recently added to or reduced their stakes in ITGR. HBK Investments L P bought a new position in shares of Integer in the 2nd quarter valued at about $14,502,000. Hsbc Holdings PLC bought a new stake in shares of Integer during the 2nd quarter valued at $3,292,000. Assenagon Asset Management S.A. acquired a new position in shares of Integer in the 2nd quarter valued at $746,000. Great Lakes Advisors LLC acquired a new position in shares of Integer in the 2nd quarter valued at $2,396,000. Finally, Nantahala Capital Management LLC bought a new position in shares of Integer in the 2nd quarter worth $10,401,172. Institutional investors own 99.29% of the company’s stock.

Integer Price Performance

Shares of ITGR stock opened at $126.64 on Monday. The stock has a 50 day moving average of $126.32 and a two-hundred day moving average of $101.46. The company has a current ratio of 3.98, a quick ratio of 2.60 and a debt-to-equity ratio of 0.73. Integer has a 12 month low of $66.00 and a 12 month high of $126.83. The company has a market capitalization of $4.31 billion, a P/E ratio of 42.50, a P/E/G ratio of 2.41 and a beta of 0.60.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, October 29th. The medical equipment provider reported $1.34 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.68 by ($0.34). The firm had revenue of $449.66 million for the quarter, compared to the consensus estimate of $456.91 million. Integer had a net margin of 5.68% and a return on equity of 11.84%. The business’s revenue for the quarter was down 3.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.79 earnings per share. As a group, equities analysts expect that Integer will post 6.09 EPS for the current year.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global medical device and advanced energy technology company. It partners with original equipment manufacturers to design and manufacture components, subassemblies and finished products used in minimally invasive and implantable medical devices.

Its medical technologies include batteries and power systems for pacemakers, implantable cardioverter-defibrillators, neurostimulators and drug-delivery systems, as well as catheter and guidewire components, coated wire, electrodes and other products used in cardiovascular, neuromodulation and other medical applications.

Integer also develops specialty batteries and power solutions for markets such as energy, aerospace and defense.